Omeprazole suppresses endothelial calcium response and eNOS Ser1177 phosphorylation in porcine aortic endothelial cells.

BACKGROUND

Although high doses of proton pump inhibitors can elicit an anticancer effect, this strategy may impair vascular biology. In particular, their effects on endothelial Ca signaling and production of endothelium-derived relaxing factor (EDRF) are unknown. To this end, we investigated the effects of high dosages of omeprazole on endothelial Ca responses and EDRF production in primary cultured porcine aortic endothelial cells.

METHODS AND RESULTS

Omeprazole (10-1000 μM) suppressed both bradykinin (BK)- and thapsigargin-induced endothelial Ca response in a dose-dependent manner. Furthermore, omeprazole slightly attenuated Ca mobilization from the endoplasmic reticulum, whereas no inhibitory effects on endoplasmic reticulum Ca-ATPase were observed. Omeprazole decreased BK-induced phosphorylation of endothelial nitric oxide synthase (eNOS) at Ser1177 and tended to decrease BK-induced nitric oxide production. Production of prostaglandin I metabolites, especially 6-keto-prostaglandin 1α, also tended to be reduced by omeprazole.

CONCLUSION

Our results are the first to indicate that high doses of omeprazole may suppress both store-operated Ca channels and partially the G protein-coupled receptor/phospholipase C/inositol 1,4,5-triphosphate pathway, and decreased BK-induced, Ca-dependent phosphorylation of eNOS(Ser1177). Thus, high dosages of omeprazole impaired EDRF production by attenuating intracellular Ca signaling.